Laguna Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch Laguna Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm (NCT02454283) | Laguna Pharmaceuticals, Inc. | 2015-09-01 |
| Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm (NCT01691313) | Laguna Pharmaceuticals, Inc. | 2012-11-01 |
Track Laguna Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.